
Exact Sciences
North America, Wisconsin, United States, Madison
Description
Exact Sciences is the developer and manufacturer of Cologuard, a non-invasive screening test for the early detection of colorectal cancer.
Investor Profile
Exact Sciences has backed more than 50 startups, with 1 new investments in the last 12 months alone. The firm has led 48 rounds, about 96% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Grant, Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Non Profit, Medical.
- Led 1 rounds in the past year.
Stage Focus
- Grant (96%)
- Series A (2%)
- Series B (2%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Non Profit
- Medical
- Wellness
- Hospital
- Dental
- Communities
- Education
- Fitness
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.